admin

The order wins, if confirmed, would further strengthen the company’s already robust order book, which stood at ₹16,300 crore at the end of the December quarter (Q3).

Gold and silver futures rose on MCX and globally, supported by Akshaya Tritiya demand and global cues, analysts see short term volatility but strong long term outlook for gold.

HDFC AMC Q4 FY26 profit fell 2% YoY and 19% QoQ to ₹623.3 crore, missing estimates, FY26 PAT rose 16%, board proposed ₹54 per share dividend.

Ramesh Damani said Mark Mobius helped bring global investor focus to India and other emerging markets. He highlighted Mobius’ view that volatility creates opportunity and said investors should stay invested through cycles. Damani added that markets may stabilise as geopolitical…

Devang Mehta, Deputy Managing Director & CIO – Equity NDPMS, Spark Private Wealth Management, said consumption trends are improving with demand and margins showing recovery across companies, making the sector worth tracking over the medium term. He highlighted earnings visibility…

Enviro Infra Engineers said it continues to benefit from rising government spending on water infrastructure and increasing investments in renewable energy and storage solutions.

Kotak has upgraded its stance on NACL Industries and Hindalco Industries, factoring in recent price tailwinds, updated commodity assumptions, and revised foreign exchange forecasts.

Mark Mobius, one of the most influential emerging markets investors, passed away at 89. A regular guest on CNBC-TV18 for over 26 years, he once joined us in Mumbai to launch our first market summit. “If you want to understand…

14 analysts have coverage on REC, of which 13 have a “buy” recommendation on the stock, while 15 analysts cover PFC and all of them have a “buy” rating on the stock.

With this approval, Alembic Pharma now has a cumulative total of 236 ANDA approvals from the USFDA, including 218 final approvals and 18 tentative approvals.